基于补充和替代伊朗医学的饮食修改对患有二级进展性多发性硬化症的患者的影响:随机对照临床试验
Amir Reza Moravejolahkami1, Saeid Hadi1, Vahid Hadi1
1Department of Health and Nutrition, Faculty of Medicine, AJA University of Medical Sciences, Tehran, Iran.
Journal of integrative and complementary medicine
|June 12, 2023
概括
使用补充和替代伊朗医学 (CAIM) 的饮食改变显著改善了二次进展性多发性硬化症 (SPMS) 患者的炎症和症状. 需要进一步的研究来证实这些对SPMS管理的有希望的结果.
科学领域:
- 综合医学是一个整体医学.
- 神经学 神经学
- 饮食科学 饮食科学
背景情况:
- 二次进展性多发性硬化症 (SPMS) 在管理方面提出了重大挑战.
- 目前对SPMS的治疗有局限性,需要探索补充方法.
- 饮食干预越来越多地被认为是对治疗慢性炎症的潜在作用.
研究的目的:
- 评估基于补充和替代伊朗医学 (CAIM) 对SPMS患者的饮食修改的疗效.
- 调查基于波斯医学的适度性饮食对SPMS关键临床标志物的影响.
主要方法:
- 这是一项随机对照试验,涉及70名SPMS患者.
- 干预组接受了基于CAIM的饮食;对照组接受了通常的护理和一般的饮食建议.
- 在2个月内评估血清hs-CRP,ESR,EDSS,MFIS,STAI,GPS,GSRS,人体测量和QOL.
主要成果:
- 在hs-CRP,MFIS,GSRS,GPS和QOL的干预组中观察到显著的改善.
- 两组之间在ESR,EDSS,STAI或人体测量测量方面没有发现显著差异.
- 基于CAIM的饮食对SPMS的炎症标志物和特定的临床症状产生了积极的影响.
结论:
- 由CAIM指导的饮食修改显示出改善SPMS炎症和临床表现的潜力.
- 这些发现表明,基于CAIM的饮食干预措施是SPMS的可行补充策略.
- 需要进一步严格的临床试验来证实这些初步结果并确定长期疗效.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
362
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
362
01:29Inflammatory Bowel Disease IV: Pharmacological Management
158
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
158
01:26Atherosclerosis III: Management
15
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
15
01:29Chronic Pancreatitis II: Collaborative Care
116
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
116
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
252
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
252
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
202
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
202